Evidence Summary
Evidence Level: Anecdotal
Mechanism: Not specified
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Systematic review + obs data ~34% success for hemodynamic benefit. VA guideline moderate evidence. 2.5-10mg TID. Vasopressor; supine hypertension risk. Useful for hypotensive POTS.